<DOC>
	<DOCNO>NCT00665444</DOCNO>
	<brief_summary>The propose study non-randomized , open label trial examine potential reduce metabolic risk factor patient bipolar I disorder improve psychiatric functional outcome . To accomplish objective , plan conduct 5-month intervention 50 obese overweight adult diagnose bipolar disorder . The study divide three step : Screening , Baseline Period ( cross taper aripiprazole , 2 month duration ) , Months 1-3 ( continued aripiprazole treatment ) . Subjects assess meet study psychiatrist least bi-monthly throughout participation , frequently clinically necessary ( e.g . medication taper manic/depressive symptom emerge ) . Brief clinical assessment conduct visit . More thorough assessment conduct Baseline , Week 2 , Month 3 .</brief_summary>
	<brief_title>Study Aripiprazole Reduce Medical Risks Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Age 18 65 year 2 . Body mass index ( BMI ) &gt; =25 ; 3 . Currently take regimen medication bipolar disorder likely cause , sedation , weight gain undesirable metabolic effect ; 4 . Able give basic inform consent 5 . Meets DSMIV criterion lifetime bipolar I II disorder presently sustain remission ( CGI BP &lt; 3 previous 8week period measure complete psychiatric history screen patient report . ) 6 . Epworth Scale Score &gt; 7 7 . Women childbearing potential must agree use doctorapproved birth control throughout participation study 1 . Unwilling unable comply study requirement ( i.e. , complete form , attend schedule evaluation ) 2 . Not competent provide inform consent opinion investigator 3 . Ultrarapid cycling ( &gt; 4 episode per month ) bipolar I disorder 4 . Unstable severe medical illness require immediate intensive medical attention , When appropriate , patient reconsider inclusion study if/when medical condition become compatible participation protocoldriven research study 5 . Women plan become pregnant , currently pregnant , breastfeed ; 6 . Current substance dependence ; however , subject substance abuse/use , first positive drug screen , another drug screen repeat . If drug screen positive , subject exclude . If second drug screen negative , subject consider study ; 7 . Subjects previously fail adequate trial aripiprazole . 8 . Subjects suicide attempt past 2 year ; 9 . Subjects history inpatient admission past 1 year ; 10 . Subjects history homicidal ideation ; 11 . Any subject PI deem potential risk participate study outweigh potential benefit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>sedation</keyword>
	<keyword>overweight</keyword>
	<keyword>Abilify</keyword>
	<keyword>medication</keyword>
</DOC>